CClinicalTrials.gg
CompletedNCT05531812Updated Oct 2, 2023

Impact of Graduating to Resilience on Child Development in Uganda

An interventional study of G2R with individual coaching and G2R with group coaching in Child Development, sponsored by Doug Parkerson. Completed at 1 site in Uganda. Open to participants aged 27 Months to 42 Months. Per ClinicalTrials.gov, last updated 2023-10-02.

Sponsored by Doug Parkerson · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,515
Allocation
Randomized
Ages
27 Months to 42 Months
Sex
All
01

Study summary

This study is an intervention trial that aims to estimate the impact of the Graduating to Resilience (G2R) program on child development in Uganda. In previous trials, the G2R program has generated large, positive impacts on household assets, consumption, income and food security. The investigators will revisit a sample of households enrolled in a G2R trial conducted in Uganda in 2019-2021 (AEARCTR-0004080) and assess children born during the intervention period.

02

Conditions studied

  • Child Development
03

In context

Lead sponsor

This is the only study on the registry with Doug Parkerson as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
27 Months to 42 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Child born between April 2019 and June 2020
  • Household enrolled in G2R intervention trial

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,515 participants (actual)

Study arms

  • Experimental
    G2R with individual coaching

    Other: G2R with individual coaching

  • Experimental
    G2R with group coaching

    Other: G2R with group coaching

  • No intervention
    Control

Interventions

  • OtherG2R with individual coaching

    1. Consumption support in the form of a monthly cash transfer for 12 months, totaling US$280-$320; 2. A one-time "asset" transfer of US$300 delivered \~7 months into the program; 3. Enrollment, training, and support to participate in a Village Savings and Loans Association (VSLA) or similar group; 4. Individual coaching at home from a trained coach using a structured curriculum focused on essential topics, including: child nutrition; infant and young child feeding (IYCF) best practices; Water, Sanitation and Hygiene (WASH) practices and practical solutions; preventative health care; positive parenting and life skills; gender; climate risk mitigation strategies; rights, linkages, and access to services.

  • OtherG2R with group coaching

    1. Consumption support in the form of a monthly cash transfer for 12 months, totaling US$280-$320; 2. A one-time "asset" transfer of US$300 delivered \~7 months into the program; 3. Enrollment, training, and support to participate in a Village Savings and Loans Association (VSLA) or similar group; 4. Group coaching in a community setting from a trained coach using a structured curriculum focused on essential topics, including: child nutrition; infant and young child feeding (IYCF) best practices; WASH practices and practical solutions; preventative health care; positive parenting and life skills; gender; climate risk mitigation strategies; rights, linkages, and access to services.

06

What researchers measure

Primary outcomes

  1. Bayley Scale of Infant and Toddler Development version III (BSID-III) cognitive z-score

    Raw item data will be converted to norm-referenced z-scores using the Bayley-III Scoring Assistant software.

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  2. BSID-III language z-score

    Raw item data will be converted to norm-referenced z-scores using the Bayley-III Scoring Assistant software.

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  3. BSID-III motor z-score

    Raw item data will be converted to norm-referenced z-scores using the Bayley-III Scoring Assistant software.

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  4. BSID-III social-emotional z-score

    Raw item data will be converted to norm-referenced z-scores using the Bayley-III Scoring Assistant software.

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  5. BSID-III adaptive behavior z-score

    Raw item data will be converted to norm-referenced z-scores using the Bayley-III Scoring Assistant software.

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

Secondary outcomes

  1. Caregiver Reported Early Development Instruments (CREDI) cognitive z-score

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure (Waldman et al. 2021).

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  2. CREDI language z-score

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure (Waldman et al. 2021).

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  3. CREDI motor z-score

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure (Waldman et al. 2021).

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

  4. CREDI social-emotional z-score

    The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure (Waldman et al. 2021).

    Time frame: Assessed once approximately 43 months after launch of the intervention in February 2019

07

Study locations

1 site
  • Innovations for Poverty Action Uganda
    Kampala, Uganda
08

References and documents

Publications

  • Waldman M, McCoy DC, Seiden J, Cuartas J, CREDI Field Team, Fink G. Validation of motor, cognitive, language, and socio-emotional subscales using the caregiver reported early development instruments: an application of multidimensional item factor analysis. International Journal of Behavioral Development 2021;45(4):368-77

Study documents

  • Statistical analysis plan · Aug 31, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Study data will be published in a public repository

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05531812
Lead sponsor
Doug Parkerson
Collaborators
United States Agency for International Development (USAID), AVSI Foundation
Responsible party
Doug Parkerson (Senior Research Scientist, Director Path-to-Scale Research, Innovations for Poverty Action) — Sponsor-investigator
First posted
Sep 8, 2022
Start date
Sep 14, 2022
Primary completion
Oct 18, 2022
Completion
Oct 18, 2022
Last update
Oct 2, 2023

Study contacts

Lasse Brune, PhD
principal investigator · Northwestern University
Nathanael Goldberg, MPA
principal investigator · Innovations for Poverty Action
Dean Karlan, PhD
principal investigator · Northwestern University
Christopher Udry, PhD
principal investigator · Northwestern University
Peter Rockers, ScD
principal investigator · Boston University
Doug Parkerson, MA
principal investigator · Innovations for Poverty Action

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion